LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/Prosecutor Mehta Nets Another Jacksonville Ortho Practice
Legal & Regulatory and Reimbursement

Prosecutor Mehta Nets Another Jacksonville Ortho Practice

December 12, 2016 2 min read Premium comments

Advertisement

Prosecutor Mehta Nets Another Jacksonville Ortho Practice
Jason Mehta / Photo creation by RRY Publications, LLC / Sources: Jason Mehta and DOJ
Secondary

Another Jacksonville, Florida-based orthopedic group has agreed to settle false claims allegations with Assistant U.S. Attorney, Jason Mehta.

On December 7, 2016, Mehta and the Department of Justice (DOJ) announced that Southeast Orthopedic Specialists (SOS) agreed to pay the government $4.488 million to resolve allegations that it violated the False Claims Act.

The government alleges the group sought reimbursement for about $3 million of services that were questionable because they were not medically necessary and reasonable.

Specifically, the feds claim that SOS knowingly:

  • “Certified that it met certain standards related to the “meaningful use” of electronic health records when the practice had, in fact, not met those standards;
  • Billed for certain claims as “incident to” physician supervision when no physician was present or there was no verification of any physician being present;
  • Billed for certain claims using Modifier 25 signifying that a separate evaluation and management service was performed even when there was no such separate service;
  • Billed for certain claims using Modifier 59 signifying that two procedures, rather than one, were billable even when these procedures should have more appropriately been billed as one such procedure;
  • Scheduled patients’ follow-up operative visits from 12 weeks following surgery to 14 weeks in an effort to bill for a separate visit outside the normal Medicare 90 days Diagnosis-Related Group charge;
  • Used and billed for ultrasound-guided injections routinely even in the absence of medical necessity; and
  • Billed for certain physical therapy claims using Modifier KX so as to exceed the Medicare cap on physical therapy, despite the absence of medical necessity.”

Corporate Integrity Agreement

SOS admitted no wrongdoing as part of the settlement, which required the practice to sign a corporate integrity agreement and hire a third-party auditor to review future claims.

The practice has 13 board-certified physicians on staff and employs about 200 other personnel in half a dozen locations throughout Northeastern Florida.

The U.S. Department of Health and Human Services, Office of Inspector General assisted in the case. Mehta said SOS cooperated immediately when confronted with the problems, and the settlement soon followed.

Assistant U.S. Attorney Mehta is making a name for himself in northern Florida. This past August, the prosecutor reached a $7.14 false claims settlement with Jacksonville-based Coastal Spine and Pain over allegations the practice performed medically unnecessary drug screening procedures.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy